Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Artemis Medicare Services Limited (NSE: ARTEMISMED), ISIN INE025R01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ARTEMISMED last traded at ₹309.10 (+0.98%), with a 52-week range of ₹203.35 to ₹378.80 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 58.39%, FIIs 12.45%, DIIs 1.91%, mutual funds 0.92%.
EquiSense Score (ECS): 60/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.